Clinical Neuropharmacology of Hypothalamic Releasing Factors
- 29 June 1972
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 286 (26) , 1391-1397
- https://doi.org/10.1056/nejm197206292862606
Abstract
DURING the past decade developments in the area of neuroendocrine research have transformed it into one of the most exciting and rapidly changing aspects of endocrinology. The chemotransmitter concept of neural control of the anterior pituitary gland has been established, several of the hypothalamic releasing factors or releasing hormones have been purified, characterized and even synthesized, and extensive investigation of neuropharmacologic control mechanisms has been performed. Several excellent reviews and symposia have recently appeared.1 2 3 4 5 6 7 This review will attempt to assess the current concepts of the neurochemical basis of hypothalamic releasing-factor control and to summarize at the clinical level the present . . .Keywords
This publication has 49 references indexed in Scilit:
- Effect of Drugs on Amines in the CNSAnnual Review of Pharmacology, 1971
- Brain-Adenohypophysial Communication in MammalsAnnual Review of Physiology, 1971
- Adrenergic Blockade and the Corticosteroid and Growth Hormone Responses to MethylamphetamineNature, 1970
- The influence of neural blocking agents implanted into the hypothalamus of the rat on induced deciduomata formationLife Sciences, 1970
- Influence of amphetamines on plasma corticosteroid and growth hormone levels in manBMJ, 1969
- Growth hormone secretion during sleepJournal of Clinical Investigation, 1968
- Corticotropin Release: Inhibition by Intrahypothalamic Implantation of AtropineScience, 1968
- THE PARTICIPATION OF THE NERVOUS SYSTEM IN THE CONTROL OF THYROID FUNCTION*Annals of the New York Academy of Sciences, 1960
- Effect of chlorpromazine and of reserpine on adrenocortical functionPsychiatric Quarterly, 1960
- HORMONAL EFFECTS OF CHLORPROMAZINEThe Lancet, 1956